BVT Discount Zert RHHVF 27.09.202.../ DE000VM3P713 /
29/04/2024 10:30:55 | Var.+0.510 | Denaro12:00:10 | Lettera12:00:10 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
225.710EUR | +0.23% | - Quantità in denaro: - |
- Quantità in lettera: - |
Roche Holding Ltd | - - | 27/09/2024 | Call |
GlobeNewswire
11:06
Allot to Release First Quarter 2024 Earnings and Host Conference Call on May 29, 2024
GlobeNewswire
11:00
CN Moving to Kevric's Landmark Redevelopment at 600 De La Gauchetière Street West
GlobeNewswire
10:27
Chinese variety show "Ride the Wind 2024" is catapulting international talents onto the global stage
GlobeNewswire
10:00
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Inv...
GlobeNewswire
10:00
EQIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Equinix, Inc. Investors with S...
GlobeNewswire
10:00
ASTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AST SpaceMobile, Inc. Investor...
GlobeNewswire
10:00
LNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lincoln National Corporation In...
GlobeNewswire
10:00
CMP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Compass Minerals International,...
GlobeNewswire
10:00
ADSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Autodesk, Inc. Investors with ...
GlobeNewswire
08:35
Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of...